Open AccessJournal Article
Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia.
TLDR
Findings suggest a novel mechanism by which eosinophils specifically accumulate in pathologic human tissues, and IL-5 may represent an important cytokine responsible for the delay of the death process in eos inophils in nasal polyps.Abstract:
Nasal polyps, which often occur in association with allergic rhinitis and asthma, are characterized by a marked infiltration of eosinophils. Using a method for detecting eosinophils with DNA strand breaks, we found direct evidence for inhibition of eosinophil apoptosis in this model of tissue eosinophilia. By using Southern blot analysis linked to reverse transcription-PCR, we detected a mRNA signal specific for IL-5 in all nasal polyps. The identification of IL-5 as a major eosinophil survival factor was confirmed by ELISA measurements using tissue homogenates. Moreover, immunohistochemical analysis of the nasal polyp tissues demonstrated that IL-5 was localized in lymphocytes, mast cells, and eosinophils. Treatment of the eosinophil-infiltrated tissue with neutralizing anti-IL-5 mAb induced eosinophil apoptosis and decreased tissue eosinophilia. Therefore, IL-5 may represent an important cytokine responsible for the delay of the death process in eosinophils in nasal polyps. In addition, a previously suggested IL-4-dependent specific recruitment of eosinophils into the inflamed tissue could be excluded by our studies. Taken together, these findings suggest a novel mechanism by which eosinophils specifically accumulate in pathologic human tissues.read more
Citations
More filters
Journal ArticleDOI
Allergic Rhinitis and Its Impact on Asthma
TL;DR: This systematic review and meta-analyses confirmed the findings of a previous study published in “Rhinitis and Asthma: Causes and Prevention, 2nd Ed.” (2015) as well as new findings of “Mechanisms of Respiratory Disease and Allergology,” which confirmed the role of EMTs in the development of these diseases.
Journal ArticleDOI
Role of reactive oxygen species (ROS) in apoptosis induction
TL;DR: The role of ROS in the regulation of apoptosis, especially in inflammatory cells, is focused on, with particular attention to mitochondria.
Journal ArticleDOI
Adult chronic rhinosinusitis: Definitions, diagnosis, epidemiology, and pathophysiology
Michael S. Benninger,Berrylin J. Ferguson,James A. Hadley,Daniel L. Hamilos,Michael R. Jacobs,David W. Kennedy,Donald C. Lanza,Bradley F. Marple,J. David Osguthorpe,James A. Stankiewicz,Jack B. Anon,James C. Denneny,Ivor A. Emanuel,Howard L. Levine +13 more
TL;DR: A Task Force was convened by the Sinus and Allergy Health Partnership to summarize much of the current and important information available regarding the prevalence, economic impact, pathophysiology, common inflammatory mediators, and the role of infectious microbes such as bacteria and fungi in CRS to establish a standard and usable definition.
Journal ArticleDOI
Rhinosinusitis: Establishing definitions for clinical research and patient care
Eli O. Meltzer,Daniel L. Hamilos,James A. Hadley,Donald C. Lanza,Bradley F. Marple,Richard A. Nicklas,Claus Bachert,James N. Baraniuk,Fuad M. Baroody,Michael S. Benninger,Itzhak Brook,Badrul A. Chowdhury,Howard M. Druce,Stephen R. Durham,Berrylin J. Ferguson,Jack M. Gwaltney,Michael A. Kaliner,David W. Kennedy,Valerie J. Lund,Robert M. Naclerio,Ruby Pawankar,Jay F. Piccirillo,Patricia E. W. Rohane,Ronald A. Simon,Raymond G. Slavin,Alkis Togias,Ellen R. Wald,S. James Zinreich +27 more
TL;DR: An expert panel from multiple disciplines developed definitions for rhinosinusitis and outlined strategies for design of clinical trials and reached consensus on definitions and strategies for clinical research on acute presumed bacterial rhinosineitis, chronic rhinosinitis with polyposis, and classic allergic fungal rhinusitis.
Journal ArticleDOI
Reslizumab for Poorly Controlled, Eosinophilic Asthma: A Randomized, Placebo-Controlled Study
Mario Castro,Sameer K. Mathur,Frederick E. Hargreave,Louis-Philippe Boulet,Fang Xie,James B. Young,H. Jeffrey Wilkins,Timothy Henkel,Parameswaran Nair +8 more
TL;DR: Patients receiving reslizumab showed significantly greater reductions in sputum eosinophils, improvements in airway function, and a trend toward greater asthma control than those receiving placebo.